Agitation in Alzheimer Disease

Disease State Hub

Featured

Research Summary
Research Summary
09/25/2025
Anthony Calabro, MA
In a phase 3 randomized controlled trial, escitalopram was not associated with significant improvement in agitation symptoms in patients with Alzheimer dementia and was linked to QT interval prolongation,...
09/25/2025
3-in-30
3-in-30
09/22/2025
Miranda Manier, BA
Think you know what triggers agitation in Alzheimer disease? Prove it in 30 seconds.
09/22/2025
Pop Quiz
Pop Quiz
09/16/2025
Anthony Calabro, MA
Agitation in patients with Alzheimer disease often appears sudden and puzzling, but in many cases, it is driven by modifiable external or medical factors. Clinicians who can identify these underlying...
09/16/2025

Interactive Features

3-in-30
3-in-30
09/22/2025
Miranda Manier, BA
Think you know what triggers agitation in Alzheimer disease? Prove it in 30 seconds.
09/22/2025
Pop Quiz
Pop Quiz
09/16/2025
Anthony Calabro, MA
Agitation in patients with Alzheimer disease often appears sudden and puzzling, but in many cases, it is driven by modifiable external or medical factors. Clinicians who can identify these underlying...
09/16/2025
Pop Quiz
Pop Quiz
08/28/2025
Miranda Manier, BA
In a 2024 review, the International Psychogeriatric Association introduces a systematic method to manage agitation in patients with Alzheimer disease. Take our quiz to test your knowledge on this...
08/28/2025
Pop Quiz
Pop Quiz
07/28/2025
Kate Young
A recent study review examined the role of music therapy on quality of life in geriatric populations. Do you know how music therapy can help patients with Alzheimer disease? Take the quiz to test your...
07/28/2025
Pop Quiz
Pop Quiz
07/23/2025
Anthony Calabro, MA
In an interview with Consultant360, Paul B. Rosenberg, MD, discussed his team’s research on using dronabinol, a legal form of synthetic THC, to treat agitation in patients with Alzheimer disease. What...
07/23/2025

Clinical Insights

Video
Video
09/11/2025
Kasia Rothenberg, MD, PhD
In this video, Kasia Rothenberg, MD, PhD, describes Alzheimer disease-related agitation, details the difficulty in testing for Alzheimer disease-related agitation, looks ahead to potential treatment options...
09/11/2025
Video
Video
05/26/2025
Paul B. Rosenberg, MD
In this video, Paul B. Rosenberg, MD, discusses his team’s research on using dronabinol, a legal form of synthetic THC, to treat agitation in patients with Alzheimer disease. The study found that dronabinol...
05/26/2025
Podcast
Podcast
04/10/2025
Leslie Citrome, MD
In this podcast, Leslie Citrome, MD, MPH, talks about resources and strategies of care that caregivers of people with agitation in Alzheimer disease can implement. He talks about how caregivers can be...
04/10/2025
Conference Coverage
Conference Coverage
04/19/2024
In this video, Craig Chepke, MD, DFAPA, and Kevin Williams, MS, MPAS, PA-C provide the take-home messages from their session “Agitation in Alzheimer’s Dementia: Progress for an Age-Old Problem” at our...
04/19/2024
Video
Video
03/25/2024
Brenden P. Lucy, MD
In a small clinical trial, researchers found that patients taking suvorexant, an FDA-approved treatment for insomnia, had reduced levels of amyloid beta (amyloid-β) and tau phosphorylation proteins, which...
03/25/2024